Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Rognoni

Showing results (11-20 of 130) with videos related to

Pageof 13
Sort By:
Reviews on Recent Clinical Trials|April 29, 2010
Manual thrombectomy during primary coronary intervention in acute myocardial infarction: a brief reviewAndrea Rognoni, Luigi Corrado, Sergio Maccio, et al.
Journal of Thrombosis and Thrombolysis|April 6, 2023
Lipoprotein associated- phospholipase A2 in STEMI vs. NSTE-ACS patients: a marker of cardiovascular atherosclerotic risk rather than thrombosisMonica Verdoia, Roberta Rolla, Rocco Gioscia, et al.
Thrombosis and Haemostasis|April 18, 2022
Safety and Efficacy of Selective, Clopidogrel-Based Strategies in Acute Coronary Syndrome: A Study-Level Meta-analysisGiuseppe Patti, Leonardo Grisafi, Enrico Guido Spinoni, et al.
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|May 7, 2005
[Acute myocardial infarction after wasp sting without anaphylactic reaction]Angelo Sante Bongo, Gianluigi Fornaro, Mara Sansa, et al.
Kardiologia Polska|May 13, 2022
Low levels of vitamin D and coronary artery disease: Is it time for therapy?Monica Verdoia, Rocco Gioscia, Matteo Nardin, et al.
Cardiovascular & Hematological Agents in Medicinal Chemistry|September 12, 2012
Low--molecular weight heparins and unfractionated heparins during primary coronary interventionChiara Cavallino, Matteo Santagostino, Emanuela Facchini, et al.
Recent Patents on Cardiovascular Drug Discovery|January 7, 2011
Levosimendan: from basic science to clinical trialsAndrea Rognoni, Alessandro Lupi, Maurizio Lazzero, et al.
Current Vascular Pharmacology|June 7, 2024
Antiplatelet Effect of Low-Dose Prasugrel in Elderly Patients Undergoing Percutaneous Coronary InterventionsMonica Verdoia, Matteo Nardin, Rocco Gioscia, et al.
Journal of Interventional Cardiology|March 30, 2007
Percutaneous treatment of coronary bifurcations: lesion preparation before provisional bare metal stenting and subsequent immunosuppression with oral prednisone. The IMPRESS-Y studyFlavio Ribichini, Valeria Ferrero, Andrea Rognoni, et al.
The American Journal of Cardiology|April 18, 2007
Comparison of efficacy and safety of lower-dose to higher-dose oral prednisone after percutaneous coronary interventions (the IMPRESS-LD study)Valeria Ferrero, Flavio Ribichini, Andrea Rognoni, et al.
Pageof 13

Showing results (11-20 of 130) with videos related to

Sort By:
Pageof 13
Reviews on Recent Clinical Trials|April 29, 2010
Manual thrombectomy during primary coronary intervention in acute myocardial infarction: a brief reviewAndrea Rognoni, Luigi Corrado, Sergio Maccio, et al.
Journal of Thrombosis and Thrombolysis|April 6, 2023
Lipoprotein associated- phospholipase A2 in STEMI vs. NSTE-ACS patients: a marker of cardiovascular atherosclerotic risk rather than thrombosisMonica Verdoia, Roberta Rolla, Rocco Gioscia, et al.
Thrombosis and Haemostasis|April 18, 2022
Safety and Efficacy of Selective, Clopidogrel-Based Strategies in Acute Coronary Syndrome: A Study-Level Meta-analysisGiuseppe Patti, Leonardo Grisafi, Enrico Guido Spinoni, et al.
Italian Heart Journal. Supplement : Official Journal of the Italian Federation of Cardiology|May 7, 2005
[Acute myocardial infarction after wasp sting without anaphylactic reaction]Angelo Sante Bongo, Gianluigi Fornaro, Mara Sansa, et al.
Kardiologia Polska|May 13, 2022
Low levels of vitamin D and coronary artery disease: Is it time for therapy?Monica Verdoia, Rocco Gioscia, Matteo Nardin, et al.
Cardiovascular & Hematological Agents in Medicinal Chemistry|September 12, 2012
Low--molecular weight heparins and unfractionated heparins during primary coronary interventionChiara Cavallino, Matteo Santagostino, Emanuela Facchini, et al.
Recent Patents on Cardiovascular Drug Discovery|January 7, 2011
Levosimendan: from basic science to clinical trialsAndrea Rognoni, Alessandro Lupi, Maurizio Lazzero, et al.
Current Vascular Pharmacology|June 7, 2024
Antiplatelet Effect of Low-Dose Prasugrel in Elderly Patients Undergoing Percutaneous Coronary InterventionsMonica Verdoia, Matteo Nardin, Rocco Gioscia, et al.
Journal of Interventional Cardiology|March 30, 2007
Percutaneous treatment of coronary bifurcations: lesion preparation before provisional bare metal stenting and subsequent immunosuppression with oral prednisone. The IMPRESS-Y studyFlavio Ribichini, Valeria Ferrero, Andrea Rognoni, et al.
The American Journal of Cardiology|April 18, 2007
Comparison of efficacy and safety of lower-dose to higher-dose oral prednisone after percutaneous coronary interventions (the IMPRESS-LD study)Valeria Ferrero, Flavio Ribichini, Andrea Rognoni, et al.
Pageof 13